Director, Investor Relations & Communications

About Peptilogics

Peptilogics is a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections (MDRI). Our lead candidate, PLG0206, is a first-in-class drug that targets biofilm, a protective bacterial matrix that is the root cause of device infections across surgical categories, and has no approved cure to date. PLG0206 is currently being evaluated in a Phase 2/3 registration trial for the treatment of prosthetic joint infection (PJI), the first of multiple potential indications to treat and prevent MDRI.

About Peptilogics : Leaders in Scalable, Rational Design

Peptilogics is a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections (MDRI). Our lead candidate, PLG0206, is a first-in-class drug that targets biofilm, a protective bacterial matrix that is the root cause of device infections across surgical categories and has no approved cure to date. PLG0206 is currently being evaluated in a Phase 2/3 registration trial for the treatment of prosthetic joint infection (PJI), the first of multiple potential indications to treat and prevent MDRI.
Position Overview

The Director, Investor Relations & Communications leads all external communications tied to Peptilogics ' corporate narrative, investor engagement, and public positioning. This individual is the key point of contact for current and prospective investors, analysts, and media, ensuring consistent, transparent, and compelling messaging across every channel, and also supports strategic internal communications and cross-functional alignment around value-creating milestones. Reporting to the COO (CFO once hired), the role collaborates closely with Finance, Clinical, Regulatory, and Corporate Operations to shape disclosures, presentations, and communications strategy. The ideal candidate brings deep life-sciences IR experience, thrives in a fast-paced, high-stakes environment, and can build a compelling narrative for a category-defining asset where there may be no clear analogs of success, building the investor infrastructure and external positioning needed to support future raises and long-term market shaping.
Essential Functions

- Develop and execute Peptilogics ' investor-relations strategy, including calendar planning, proactive outreach, content creation, and engagement tracking

- Serve as primary point of contact for current and prospective investors, analysts, and relevant media

- Own development and maintenance of all IR materials, investor decks, fact sheets, financing announcements, press releases, and Q&A documents

- Manage public-facing channels, including the corporate website and social platforms, ensuring timely, accurate, compliant, and consistent messaging

- Coordinate investor and analyst engagement across conferences, non-deal roadshows, and industry events

- Lead message development for key milestones, clinical readouts, regulatory updates, financings, grant awards, and commercial progress

- Track and report investor sentiment, sector trends, competition, and peer communications to inform executive decisions and positioning

- Manage IR/PR agency relationships to support execution, visibility, and crisis response

- Prepare executives for investor meetings, speaking engagements, and media with tailored briefings and coaching

- Operationalize a recurring investor-update cadence (quarterly reports, post-Board updates, ad hoc news flow) and translate internal insights into investor-facing narrative

- Partner with Clinical, Regulatory, CMC, Legal, and Finance to ensure technical accuracy, compliance, and alignment in public-facing documents

- Support internal communications and collaborate with Corporate Operations for consistency across internal and external messaging

- Contribute to Board materials and corporate reporting tied to strategic communications and investor engagement

- Support presence at scientific conferences, trade shows